Pictilisib (GDC-0941)

Catalog No.S1065

Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM in cell-free assays, with modest selectivity against p110β (11-fold) and p110γ (25-fold). Phase 2.

Price Stock Quantity  
USD 240 In stock
USD 120 In stock
USD 170 In stock
USD 370 In stock
USD 970 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Pictilisib (GDC-0941) Chemical Structure

Pictilisib (GDC-0941) Chemical Structure
Molecular Weight: 513.64

Validation & Quality Control

Cited by 57 publications:

7 customer reviews :

Quality Control & MSDS

Related Compound Libraries

Pictilisib (GDC-0941) is available in the following compound libraries:

PI3K Inhibitors with Unique Features

  • Pan PI3K Inhibitor

    LY294002 Pan-PI3Kα/δ/β inhibitor, IC50=0.5 μM/0.57 μM/0.97 μM.

  • Most Potent PI3K Inhibitor

    Duvelisib (IPI-145, INK1197) PI3K δ, IC50=1 nM.

  • FDA-approved PI3K Inhibitor

    CAL-101 (Idelalisib, GS-1101) Approved by FDA for Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma.

  • Newest PI3K Inhibitor

    GSK2636771 Potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines.

Product Information

  • Compare PI3K
    Compare PI3K Products
  • Research Area
  • Inhibition Profile
  • Pictilisib (GDC-0941) Mechanism
  • Combination Therapy
    Combination Therapy

Product Description

Biological Activity

Description Pictilisib (GDC-0941) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM in cell-free assays, with modest selectivity against p110β (11-fold) and p110γ (25-fold). Phase 2.
Targets p110α [1]
(Cell-free assay)
p110δ [1]
(Cell-free assay)
p110β [1]
(Cell-free assay)
p110γ [1]
(Cell-free assay)

 View  More

IC50 3 nM 3 nM 33 nM 75 nM
In vitro GDC-0941 is equipotent against PI3Kα and PI3Kδ as well as PI3Kα mutants E545-K and H1047-R, displaying modest levels of selectivity against PI3Kβ (10-fold) and PI3Kγ (25-fold), and greater levels of selectivity against members of PI3K class II, III, and IV, including C2β, Vps34, DNA-PK, and mTOR. GDC-0941 potently inhibits the phosphorylation of Akt in U87MG, PC3, and MDA-MB-361 cells with IC50 of 46 nM, 37 nM, and 28 nM, respectively. GDC-0941 inhibits the proliferation of U87MG, A2780, PC3, and MDA-MB-361 cells with IC50 of 0.95 μM, 0.14 μM, 0.28 μM, and 0.72 μM, respectively. [1] GDC-0941 treatment potently inhibits the proliferation of both trastuzumab-sensitive and -insensitive HER2-amplified cells with IC50 of 149-944 nM. GDC-0941 inhibits proliferation of HER2-amplified cells that harbor PIK3CA mutations with IC50 of <500 nM, and effectively inhibits both proliferation and viability of HER2-amplified breast cancer cells that are resistant to trastuzumab due to PTEN loss. [2] GDC-0941 significantly inhibits the growth of HCT116, DLD1 and HT29 cells with GI50 of 1081 nM, 1070 nM and 157 nM, respectively. [3] GDC-0941 inhibits tumor cell proliferation, induces apoptosis and suppresses centroblast population. [4]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
Sf9NX;D[nUzU2mwYYPlJGF{e2G7NF7qTpMyKGh?M4T3eWROW09?NWrOWXpzUW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDQTVNMKHBzMUDk[Yx1[SCneIDy[ZN{\WRiaX6gV4Y6KGOnbHzzJINw\XiycnXzd4lv\yCyOEXhcJBp[SC5aYToJGlEPTBib3[gNE4xODNizszNM1HYXlE5PzV2NkW0
Sf9NYDLc4lkU2mwYYPlJGF{e2G7NHnCXncyKGh?M1\lTmROW09?NFizRnlKdmirYnn0bY9vKG:oIHj1cYFvKHKnY3;tZolv[W62IGDJN2sheDFzMHLleIEhUDFyNEetVkBufXSjboSg[ZhxemW|c3XkJIlvKFOoOTDj[YxteyClb3X4dJJme3OrbnegdFg2[WyyaHGge4l1cCCLQ{WwJI9nKDBwMECzJO69VQ>?M4PIdFE5PzV2NkW0
Sf9NFTmRmZMcW6jc3WgRZN{[Xl?NInaTFEyKGh?MUHEUXNQMmjOTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCSSUPLJJAyOTCkZYThJGU2PDVvSzDteZRidnRiZYjwdoV{e2WmIHnuJHNnQSClZXzsd{Bkd2W6cILld5NqdmdicEi1ZYxxcGFid3n0bEBKSzVyIH;mJFAvODB|IN88US=>M3THXFE5PzV2NkW0
Sf9MUHLbY5ie2ViQYPzZZk>MnToNUBpMVjEUXNQNIC5PYVKdmirYnn0bY9vKG:oIHj1cYFvKHKnY3;tZolv[W62IGDJN2sheDFzMHLleIEh\XiycnXzd4VlKGmwIGPmPUBk\WyuczDjc4V5eHKnc4PpcocheDh3YXzwbIEhf2m2aDDJR|UxKG:oIECuNFM{KM7:TR?=M4XLU|E5PzV2NkW0
Sf9MUPLbY5ie2ViQYPzZZk>NYfvS5hxOSCqNEDGXWhFVVORNV74eYlqUW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDQTVNMKHBzMUDhcJBp[SCneIDy[ZN{\WRiaX6gV4Y6KGOnbHzzJINw\XiycnXzd4lv\yCyOEXhcJBp[Q>?NYXiO4xbOTh5NUS2OVQ>
MDA-MB-361NU\MSop3TnWwY4Tpc44hSXO|YYm=MUGyJIg>M4DubWROW09?MlTDTY5pcWKrdHnvckBw\iCDa4SgV4VzPDd|IIDoc5NxcG:{eXzheIlwdiCrbjDoeY1idiCPRFGtUWIuOzZzIHPlcIx{KHerdHigVGlMO0ODIFW1OFUuUyCvdYTheIlwdiC5aYToJGlEPTBib3[gNE4xOjhizszNMlnNNVg4PTR4NUS=
PC3NFjEUG5HfW6ldHnvckBCe3OjeR?=Mn;TNkBpNVK4eHU3TE2VTx?=NGTmTm9KdmirYnn0bY9vKG:oIFHreEBU\XJ2N{OgdIhwe3Cqb4L5cIF1cW:wIHnuJHBVTU5vboXscEBpfW2jbjDQR|Mh[2WubIOge4l1cCCLQ{WwJI9nKDBwMEO3JO69VQ>?NFu2eFMyQDd3NE[1OC=>
U87MGMXTGeY5kfGmxbjDBd5NigQ>?NYPGNGJpOiCqMX3EUXNQMn24TY5pcWKrdHnvckBw\iCDa4SgV4VzPDd|IIDoc5NxcG:{eXzheIlwdiCrbjDQWGVPNW63bHygbJVu[W5iVUi3UWch[2WubIOge4l1cCCLQ{WwJI9nKDBwMES2JO69VQ>?MWixPFc2PDZ3NB?=
MDA-MB-361NVjkR|NRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFLw[Gc6PiCqNVHlO5NkTE2VTx?=MoHPRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPRFGtUWIuOzZzIHPlcIx{KHerdHigVGlMO0ODIFW1OFUuUyCvdYTheIlwdiC5aYToJGlEPTBib3[gNE44OiEQvF2=MWSxPFc2PDZ3NB?=
A2780NU\Jd4h1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmrGPVYhcA>?MUTEUXNQM3TsUWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUK3PFAh[2WubIOge4l1cCCSSVuzR2Eh[W6mIGDUSW4hdXW2YYTpc44hf2m2aDDJR|UxKG:oIECuNVQh|ryPMnXRNVg4PTR4NUS=
PC3MnjCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYO5OkBpMWHEUXNQMm\DTWM2OD1yLkK4JO69VQ>?MVOxPFc2PDZ3NB?=
U87MGNVnWU2p3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFfITlc6PiCqNUHJW|ZJTE2VTx?=MXHJR|UxRTBwOUWg{txONWC3PJVNOTh5NUS2OVQ>
Sf9MmTlT4lv[XOnIFHzd4F6M3vMZ|MxKG2rbh?=NUnMR4dMTE2VTx?=NGm4c5dKdmirYnn0bY9vKG:oIHj1cYFvKFCLM1vnZY1u[SCneIDy[ZN{\WRiYYPz[ZN{\WRiYYOgZY1wfW62IH;mJGFVWCClb37zeY1m\CC5aYToJGlEPTBib3[gNE4xPDJizszNNEO4OIMzOjV2OEO0Ni=>
RAW 264.7NIC5RWNMcW6jc3WgRZN{[Xl?NY\zNGFEQTBibXnuMkn0SG1UVw>?M{HkUWlvcGmkaYTpc44hd2ZiaIXtZY4hWEl|S3fhcY1iKGW6cILld5Nm\CCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKEGNVDDwbI9{eGixconsZZRqd25id3n0bEBKSzVyIH;mJFAvOjl6IN88US=>M4rEZVIzPTR6M{Sy
Sf9NWnHNmpoU2mwYYPlJGF{e2G7MmLnNUBpM4jEN2lvcGmkaYTpc44hd2ZiR2PUMYZ2e2WmIHj1cYFvKHKnY3;tZolv[W62IGDJN2tj\XSjIHX4dJJme3OnZDDpckBj[WO3bH;2bZJ2eyCrbn\lZ5Rm\CCVRkmgZ4VtdHNid3n0bEBKSzVyIH;mJFAvODF5IN88US=>NULjZY01OjN3NEC2OFU>
Sf9NGr0[mNMcW6jc3WgRZN{[Xl?MlOzNUBpM{f0d2lvcGmkaYTpc44hd2ZiR2PUMYZ2e2WmIHj1cYFvKHKnY3;tZolv[W62IGDJN2tl\Wy2YTDlfJBz\XO|ZXS=MXKyN|U1ODZ2NR?=
Sf9M{PEOGtqdmG|ZTDBd5NigQ>?M1vNNlEhcA>?M3i0SWlvcGmkaYTpc44hd2ZiR2PUMYZ2e2WmIHj1cYFvKHKnY3;tZolv[W62IGDJN2to[W2vYTDlfJBz\XO|ZXS=M3TBflI{PTRyNkS1
Sf9MmfoT4lv[XOnIFHzd4F6MoqzNUBpNIL6eZRKdmirYnn0bY9vKG:oIFfTWE1nfXOnZDDoeY1idiC{ZXPvcYJqdmGwdDDQTVNM[WyyaHGg[ZhxemW|c3XkNWfwNoJkOjN3NEC2OFU>
SKOV3M1Tue2tqdmG|ZTDBd5NigQ>?NXzMTlJiOSEQvF2=MkLWNUBpMYXEUXNQM3Xxe2lvcGmkaYTpc44hd2ZiUFmzT4FteGijIHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiQXv0JHNmejR5MzDwbI9{eGixconsZZRqd25?MUOyN|M3ODN2OB?=
MCF7NIjTfVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFTMXowyKM7:TR?=NGmyRnI6PiCqM33WN2ROW09?NH:3Z2pIUTVyPUCuNFcxOiEQvF2=M2D6T|I{OzZyM{S4
SKOV3NHPQbGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXSxJO69VQ>?MYC5OkBpNX7MNHpsTE2VTx?=NHT0XXZIUTVyPUCuNVQ4PiEQvF2=NX;CNGZPOjN|NkCzOFg>
PC3NI\q[VNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3fmRVczKGh?MkTCSG1UVw>?Mn;OTWM2OD1yLkK4JO69VQ>?M361bVIyQThzN{G0
MCF7.1MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFHIfpc4OiCqM2jadGROW09?MlPmRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPQ1[3MlEh[2WubIOg[ZhxemW|c3nu[{BJTVJ{IHflcoUhf2m2aDDJR|UxKG:oIECuNlgh|ryPMXWyNVk5OTdzNB?=
MCF7-neo/Her2NI\vVVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3rwbVczKGh?NGfxb|NFVVORMn34TWM2OD1yLkK5JO69VQ>?M4qzOFI{PjZ{OUCz
MCF7-neo/Her2MWTLbY5ie2ViQYPzZZk>NVLqPG9uUW6qaXLpeIlwdiCxZjDQTVNM[WyyaHGgZZN{\XO|ZXSgZZMhemWmdXP0bY9vKG:oIFHLWEBxcG:|cHjvdplt[XSrb36gZZQhWzR5MzD3bZRpKEmFNUCgc4YhOC5yMEeg{txOMVuyN|Y3OjlyMx?=
PC3M1TBUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFXEc4c4OiCqNVy0UYhNTE2VTx?=MYjFR|UxRTBwM{Sg{txOMV[yNVk5PTZ|OR?=
MCF7.1MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlzyO|IhcA>?MkLSSG1UVw>?NW\v[WwzSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4NjFiY3XscJMh\XiycnXzd4lv\yCSSUPLZYxxcGFibYX0ZY51KHerdHigSWM2OCCxZjCwMlM6KM7:TR?=Mn;qNlE6QDV4M{m=
PC3M1zY[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3OwNVczKGh?MUfEUXNQM{jhOWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUFOzJINmdGy|IHTl[olkcWWwdDDpckBRXEWQIIfpeIghUUN3MDDv[kAxNjN7IN88US=>M1nIPFIxODVyNk[5
MCF7.1MljHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MofQO|IhcA>?MYjEUXNQMmP2RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPQ1[3MlEh[2WubIOg[ZhxemW|c3nu[{BRUTONYXzwbIEhdXW2YX70JJdqfGhiSVO1NEBw\iByLkO0JO69VQ>?MnTFNlAxPTB4Nkm=
MCF7.1M4HVe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGWxS2c4OiCqM2LaTGVEPTB;MD63NkDPxE1?NHjtNFYzODN2Nk[1Oi=>
NCI-H1975M{TyN2N6fG:2b4jpZ{BCe3OjeR?=NXrEbVJOPzJiaB?=NHrENJBKSzVyPUCuNlch|ryPNHq2RpIzOzB3OUW0OS=>
H460NETuNnREgXSxdH;4bYMhSXO|YYm=MUm3NkBpNXn4[5hHUUN3ME2wMlg4KM7:TR?=MUGyN|A2QTV2NR?=
HT-29Mnu2R5l1d3SxeHnjJGF{e2G7MlLqO|IhcA>?MXrJR|UxRTBwNk[g{txOMWmyN|A2QTV2NR?=
HepG2NXu0c3luS3m2b4TvfIlkKEG|c3H5M3jXfVczKGh?MmXOTWM2OD1zIN88US=>MmD1NlMxPTl3NEW=
SGC7901MUfDfZRwfG:6aXOgRZN{[Xl?NWDPfnFqPzJiaB?=M1PKOmlEPTB;MT64JO69VQ>?NX3OWI5EOjNyNUm1OFU>
NCI-H226NVn0Z3RWS3m2b4TvfIlkKEG|c3H5NVu0T4ZGPzJiaB?=MlvITWM2OD1{Lkmg{txONVrGRWlqOjNyNUm1OFU>
A549MYLDfZRwfG:6aXOgRZN{[Xl?NWPKN3hsPzJiaB?=NIfsPZJKSzVyPU[uPUDPxE1?NInWSnozOzB3OUW0OS=>
U87MGMXPDfZRwfG:6aXOgRZN{[Xl?MmDCO|IhcA>?NXm3TVRuUUN3ME23Mlc4KM7:TR?=NGG3dmUzOzB3OUW0OS=>
HBC4MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1H4eYxw\0eLNUC9MVYvODNiTR?=NYXtZ5NQOjJ|M{[yOFY>
BSY1NUL5OJk5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NY\GO2VRdG:pR1m1NF0uPi57MDDNMlr0NlI{OzZ{NE[=
HBC5NGrPNIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWXsc4dIUTVyPT22MlYxKE1?M2DpdlIzOzN4MkS2
MCF7NWHodoMyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mk\0cI9oT0l3ME2tO{4{OyCPMkTnNlI{OzZ{NE[=
MDA-MB-231NYnhSJdjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mlu3cI9oT0l3ME2tOU41PiCPM4DVXFIzOzN4MkS2
U251NVm2S5hyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWXmS2hYdG:pR1m1NF0uPS53MDDNMkm5NlI{OzZ{NE[=
SF268NEnoUZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVPsc4dIUTVyPT21MlM6KE1?NUDsV4tWOjJ|M{[yOFY>
SF295NH\YR4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{Xt[Yxw\0eLNUC9MVYvOzdiTR?=MnvXNlI{OzZ{NE[=
SF539NGDrco9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYPpeoZXdG:pR1m1NF0uPi53MDDNNVrP[ZBuOjJ|M{[yOFY>
SNB75NWXkWWpzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH;wTo1td2eJSUWwQU04NjFyIF2=MkG2NlI{OzZ{NE[=
SNB78MljNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV3sc4dIUTVyPT22MlUzKE1?MnLJNlI{OzZ{NE[=
HCC2998M4\peWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEPudYltd2eJSUWwQU03NjJ7IF2=MWqyNlM{PjJ2Nh?=
KM12MkPhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3zCb4xw\0eLNUC9MVUvPzZiTR?=MljoNlI{OzZ{NE[=
HT-29MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXTsc4dIUTVyPT22MlMxKE1?MofnNlI{OzZ{NE[=
HCT15NWL0Xox{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXEcI9oT0l3ME2tOk4yOiCPNUTIeHJmOjJ|M{[yOFY>
HCT116Mn7oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYPTcodzdG:pR1m1NF0uPS56NzDNMUGyNlM{PjJ2Nh?=
NCI-H23NYPo[lVZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVvjUHJFdG:pR1m1NF0uPS55MzDNM1PGWVIzOzN4MkS2
NCI-H226NVvsfldnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHXzVWhtd2eJSUWwQU03NjJzIF2=M1TDV|IzOzN4MkS2
NCI-H522MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2fIW4xw\0eLNUC9MVYvPThiTR?=NEGyXXIzOjN|NkK0Oi=>
NCI-H483NHm5bGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3LrRYxw\0eLNUC9MVYvPTZiTR?=MX2yNlM{PjJ2Nh?=
A549Ml\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml3vcI9oT0l3ME2tOk4yPSCPNGS2cnYzOjN|NkK0Oi=>
DMS273NG\aTXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2LY[4xw\0eLNUC9MVYvPDNiTR?=M4K0TlIzOzN4MkS2
DMS114MlzOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYflRmc{dG:pR1m1NF0uPS57MjDNM2D1W|IzOzN4MkS2
LOXIMVINHX6U5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX3sc4dIUTVyPT22MlI6KE1?MVuyNlM{PjJ2Nh?=
OVCAR3Mn3qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVrUV|RZdG:pR1m1NF0uPi55MTDNNEmwOm4zOjN|NkK0Oi=>
OVCAR4MkTmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUHLdo8zdG:pR1m1NF0uPS55NjDNNWTZepRIOjJ|M{[yOFY>
OVCAR5M1PMSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo\VcI9oT0l3ME2tOk4zPiCPNYq4c3R[OjJ|M{[yOFY>
OVCAR8NInzTFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYnDfll{dG:pR1m1NF0uPS55MzDNMVOyNlM{PjJ2Nh?=
SKOV3M2nvd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVPsc4dIUTVyPT22MlUzKE1?MUKyNlM{PjJ2Nh?=
RXF631LMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4qxWoxw\0eLNUC9MVYvQDhiTR?=NWG2SpUzOjJ|M{[yOFY>
ACHNMUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1nuSoxw\0eLNUC9MVYvODdiTR?=NFHQR4gzOjN|NkK0Oi=>
St-4M4npS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYnsc4dIUTVyPT21MlU3KE1?NV\FeZB{OjJ|M{[yOFY>
MKN1M4\ZUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWPsc4dIUTVyPT23MlA5KE1?NFPETJQzOjN|NkK0Oi=>
MKN7MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkO5cI9oT0l3ME2tOk42OCCPM3XJb|IzOzN4MkS2
MKN28MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4HpOoxw\0eLNUC9MVUvPTJiTR?=MkXWNlI{OzZ{NE[=
MKN45NVvGc4VMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGOzUXdtd2eJSUWwQU03NjV3IF2=M2ewblIzOzN4MkS2
MKN74MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4TRUYxw\0eLNUC9MVYvODJiTR?=MV2yNlM{PjJ2Nh?=
DU145Mnq4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUPz[ItHdG:pR1m1NF0uPS56NTDNM2ThZVIzOzN4MkS2
PC3MlXYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGjGOI1td2eJSUWwQU03NjZ4IF2=MXGyNlM{PjJ2Nh?=
ES5MlrSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEDvVIhKSzVyPUWwMlIyKG6PMUTTRW5ITVJ?
HHMUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{PBPGlEPTB;MUGxMlA5KG6PMWrTRW5ITVJ?
MHH-PREB-1MljYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWixfJBUUUN3ME2xNVQvOyCwTR?=NEjGeVVUSU6JRWK=
NCI-H1770NHzUNVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFS0WJhKSzVyPUGyN{45PiCwTR?=Mkn6V2FPT0WU
HuO9Mo\FS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUjLfHNHUUN3ME2yNFYvODJibl2=MWXTRW5ITVJ?
HAL-01NEC4doZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH\PPFdKSzVyPUKwOk44OyCwTR?=M4PQ[HNCVkeHUh?=
NOS-1M325XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4jH[2lEPTB;MkGxMlgzKG6PNYHi[Hh7W0GQR1XS
HGC-27NECw[mpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEfjUG9KSzVyPUKxNk42PyCwTR?=MnPoV2FPT0WU
NB69M1\XSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXXJd|BCUUN3ME2yOFUvOjdibl2=NHS5N4NUSU6JRWK=
RS4-11NVf5O4N6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M13uSWlEPTB;Mk[xMlc3KG6PNGnLdW1USU6JRWK=
DOKMkC0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXXJR|UxRTNyMT63JI5ONXv0UnFYW0GQR1XS
LB2241-RCCNXfGbHlNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1HPSWlEPTB;M{CzMlg1KG6PM3\4VHNCVkeHUh?=
NCI-H1623NX;CR|dmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVTrcFYxUUN3ME2zNFQvODhibl2=M17WdHNCVkeHUh?=
YH-13NXXBSHptT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYrWZoNyUUN3ME2zNFQvOzJibl2=M4rx[3NCVkeHUh?=
BPH-1MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTNzNDDuUS=>NGjHbpBUSU6JRWK=
AN3-CANIe3O49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3vSdGlEPTB;M{SwMlM4KG6PNUPj[op4W0GQR1XS
ES7MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGHJPIJKSzVyPUO0NU46QSCwTR?=MnHHV2FPT0WU
MDA-MB-175-VIIMlG0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX\tO|hWUUN3ME2zOVIvQTJibl2=M1;TZnNCVkeHUh?=
GAMGNVjwVFJ6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoTZTWM2OD1|N{CuPFUhdk1?NVW1bXV2W0GQR1XS
CHL-1NFG1bZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVfvN|hJUUN3ME2zO|gvPjVibl2=MXLTRW5ITVJ?
NB7M2HpSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1nKWmlEPTB;M{i5Mlg{KG6PMXLTRW5ITVJ?
MFE-280MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mkj3TWM2OD12MUiuNkBvVQ>?MoHrV2FPT0WU
HL-60NWTKRVJRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEftWlFKSzVyPUSyOU44PSCwTR?=MmjEV2FPT0WU
GCIYM4nJ[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnuwTWM2OD12M{OuPEBvVQ>?NH7ZSZlUSU6JRWK=
MDA-MB-361MnewS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVHLU4sxUUN3ME20N|kvOTNibl2=NWSzcHhiW0GQR1XS
LXF-289NGjadZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnviTWM2OD12NEiuNlchdk1?M3nobHNCVkeHUh?=
NBsusSRMkDYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NILrNm9KSzVyPUS4PE45PSCwTR?=MVHTRW5ITVJ?
KU-19-19NHPtWHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUfJR|UxRTVzNj6wO{BvVQ>?NV7ETWxMW0GQR1XS
A204Ml20S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH3QW5lKSzVyPUWyNk4{OyCwTR?=NEnKZodUSU6JRWK=
LB1047-RCCNIPJe4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVHJR|UxRTV{Mj65N{BvVQ>?NWnGXZR{W0GQR1XS
COLO-684MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXXWfIg4UUN3ME21NlMvOTFibl2=M2X0cXNCVkeHUh?=
PA-1Ml7ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHH1VHlKSzVyPUWzNk41OSCwTR?=MlLPV2FPT0WU
MG-63NVW3WHh2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH25XmtKSzVyPUW0NU4yOSCwTR?=M3\FTnNCVkeHUh?=
BHT-101MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYHoV3h6UUN3ME21OFQvQTRibl2=MnK3V2FPT0WU
NKM-1NFXLXIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUm4VpFJUUN3ME21PVMvODlibl2=Ml36V2FPT0WU
T47DMYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{nudGlEPTB;NUm3MlU3KG6PMWPTRW5ITVJ?
MOLT-4NVu1N5pwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVrzdHg6UUN3ME22NlMvPjJibl2=M2DyR3NCVkeHUh?=
IGROV-1NEOy[YtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVPJR|UxRTZ|ND6zNUBvVQ>?MXPTRW5ITVJ?
ES4NWLvSmNGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mom2TWM2OD14M{muOVQhdk1?M{TsXXNCVkeHUh?=
HuO-3N1MoXBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnzZTWM2OD14NEKuN|ghdk1?M2nQe3NCVkeHUh?=
NEC8MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkTGTWM2OD14NUOuOVchdk1?M3frNHNCVkeHUh?=
HO-1-N-1M3ey[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGewe2dKSzVyPU[1PU4yPyCwTR?=M{nITHNCVkeHUh?=
EPCL-272HMVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2rZUGlEPTB;Nki3MlIyKG6PNVvqdJVDW0GQR1XS
D-263MGMoDZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NILEdVdKSzVyPUexPE4yKG6PM4rlR3NCVkeHUh?=
MV-4-11NWPrS|VHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYThT3hLUUN3ME23NlQvOzFibl2=Mle3V2FPT0WU
SK-NEP-1MnfyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYXEV4hWUUN3ME23NlUvQTRibl2=MUjTRW5ITVJ?
SW872NIn3doxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1jNW2lEPTB;N{K3Mlg6KG6PNFXJb2pUSU6JRWK=
P30-OHKNGjRRlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX7Ud4xvUUN3ME23N|AvPzFibl2=NEf0VZRUSU6JRWK=
OMC-1M2i2fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVLJR|UxRTd3MT6wPUBvVQ>?M2XUUHNCVkeHUh?=
LoVoMoH2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEHzWVVKSzVyPUe3O{46KG6PMUjTRW5ITVJ?
LNCaP-Clone-FGCNX;ndnMzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUTJR|UxRTd7Nj6zOEBvVQ>?M4Hrd3NCVkeHUh?=
L-363NXnKOZg3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{jDc2lEPTB;N{m4MlQzKG6PMXTTRW5ITVJ?
ES8MlzUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXK0[FBQUUN3ME24NVAvPTJibl2=MlXIV2FPT0WU
697M2LnT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIDLPY1KSzVyPUizNU42PSCwTR?=MlLQV2FPT0WU
HSC-3MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH22eIpKSzVyPUizPU42PCCwTR?=M3HlfHNCVkeHUh?=
H4MnTHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXnJR|UxRTh3MD64OUBvVQ>?MoPIV2FPT0WU
QIMR-WILM2[5T2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIXMZotKSzVyPUi2OU4zKG6PNULkT3NmW0GQR1XS
OAW-42MnnVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoLBTWM2OD16N{KuNVkhdk1?MmfmV2FPT0WU
MCF7MmTZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYLLOnM5UUN3ME24PVgvPTlibl2=MX;TRW5ITVJ?
SCC-25Ml7nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFraNGVKSzVyPUmxOE4yQSCwTR?=NHewPWJUSU6JRWK=
NCI-H1563NX22R|k1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MV\JR|UxRTlzNT65PUBvVQ>?NGjqdHJUSU6JRWK=
OVCAR-5M3TrcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXHqRmFmUUN3ME25OFAvOTdibl2=NXryVWhTW0GQR1XS
HDLM-2NFTVemlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkLkTWM2OD17NEmuNkBvVQ>?NYX6THEyW0GQR1XS
NB5MlnBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVXxZ2RwUUN3ME25OVYvPiCwTR?=MlO3V2FPT0WU
NCI-H292MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1vEXGlEPTB;OUe0MlMzKG6PNIDNUGtUSU6JRWK=
A101DNHzMbXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWjJR|UxRTl7MD6xPUBvVQ>?NXzHe2NxW0GQR1XS
NCI-H1648NXH0OZRqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmDsTWM2OD17OUiuOVEhdk1?M{\veHNCVkeHUh?=
EKVXM3rhTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUTJR|UxRTFwMEGyPUDPxE1?Mn\3V2FPT0WU
SW1710MnHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHe0XIZKSzVyPUGuNFQzOzNizszNM{G1W3NCVkeHUh?=
WM-115NGPyUW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3GyRWlEPTB;MT6wOlY2PiEQvF2=M1PtbHNCVkeHUh?=
CAL-54MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVrJR|UxRTFwMEewPFEh|ryPNV2zR4IzW0GQR1XS
TGBC24TKBM4fwcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmLNTWM2OD1zLkC4NFQ2KM7:TR?=MkXiV2FPT0WU
NCI-H520MlLpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1nlTWlEPTB;MT6wPFk3PyEQvF2=NIfHPGNUSU6JRWK=
D-423MGNFjUXYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnvjTWM2OD1zLkC5PVYzKM7:TR?=NFLjRW1USU6JRWK=
BFTC-905NU\WVJBiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWrJR|UxRTFwMUO0OFkh|ryPMoXUV2FPT0WU
HTNIfZcFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXjJR|UxRTFwMUO0O|gh|ryPNIP4R4JUSU6JRWK=
CTB-1Mo\OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIP1WJVKSzVyPUGuNVQzQTNizszNNGTsfHVUSU6JRWK=
Hs-578-TMYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml\rTWM2OD1zLkG5OVY2KM7:TR?=NFvXdIdUSU6JRWK=
HuH-7NW\K[3loT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33oOmlEPTB;MT6yNFk1QSEQvF2=M{\kSnNCVkeHUh?=
LB996-RCCNXy1PHFbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1zvNWlEPTB;MT6yNlE4PyEQvF2=NXziW29FW0GQR1XS
KYSE-270NFe1XFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkO2TWM2OD1zLkK5O|M1KM7:TR?=MXvTRW5ITVJ?
A4-FukNGfUeW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4LHemlEPTB;MT6yPVk6OyEQvF2=NFrmOJRUSU6JRWK=
A498MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVTJR|UxRTFwM{C0O|Qh|ryPM1rHdnNCVkeHUh?=
SK-MEL-1MlPSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MU\JR|UxRTFwM{C2O|kh|ryPMUDTRW5ITVJ?
AU565Mn;2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIjaRYRKSzVyPUGuN|E5PjNizszNNFvNN5ZUSU6JRWK=
Saos-2M4TjVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGjnRXdKSzVyPUGuN|MzODVizszNNXroU5BbW0GQR1XS
A549NHXBVppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWDQSGJrUUN3ME2xMlM6QTdizszNNVHYdpN2W0GQR1XS
BFTC-909M1u4Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1GySWlEPTB;MT60N|MxPSEQvF2=NIDWbGNUSU6JRWK=
MDA-MB-415NWLjeHdRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV;0cI5xUUN3ME2xMlQ5Pjl{IN88US=>NYDubIt2W0GQR1XS
639-VMkP3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NE\STmpKSzVyPUGuOVAzPDVizszNMVzTRW5ITVJ?
A704NIXCfJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlfHTWM2OD1zLkWwO|g2KM7:TR?=NV\5OJZ7W0GQR1XS
PANC-03-27NX3wZXlCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{LFb2lEPTB;MT61NVQxQCEQvF2=MWLTRW5ITVJ?
SK-MEL-28NWrlOpZKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGHjXYpKSzVyPUGuOVYxQDVizszNMnXnV2FPT0WU
Ramos-2G6-4C10NITRXphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3\aWmlEPTB;MT62NFc1PiEQvF2=M{[x[3NCVkeHUh?=
HuP-T4MkS1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUXJPJlPUUN3ME2xMlYxPzd6IN88US=>MUnTRW5ITVJ?
VA-ES-BJNH7QVYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXq5XZZYUUN3ME2xMlYyOjdizszNM1LhSnNCVkeHUh?=
EFM-19MmHjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnPXTWM2OD1zLk[xPFEh|ryPNYDmVHkyW0GQR1XS
G-401MmXnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mnz4TWM2OD1zLk[yNVY1KM7:TR?=MkHWV2FPT0WU
D-566MGMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mlz6TWM2OD1zLk[yOVMh|ryPMoS5V2FPT0WU
JVM-3NVnBZZBST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33rcmlEPTB;MT62OFg4PSEQvF2=NVHCNW1NW0GQR1XS
TK10NWLTfYZiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTFwNkewPFMh|ryPNYHieJpGW0GQR1XS
BT-20MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M37iWWlEPTB;MT62PFkxOiEQvF2=Mny5V2FPT0WU
EGI-1MofhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn7MTWM2OD1zLki0O|AyKM7:TR?=MVHTRW5ITVJ?
EW-16MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYfDeHhkUUN3ME2xMlg2OTh{IN88US=>MnPhV2FPT0WU
NCI-H2228NECyNYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NY\QeHk1UUN3ME2xMlg2OjB|IN88US=>NWO1[2h4W0GQR1XS
BB49-HNCNIfUNVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1vlWGlEPTB;MT64PFY6OiEQvF2=MlrMV2FPT0WU
G-402MmHjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2m0d2lEPTB;MT64PVc6PyEQvF2=Mkn3V2FPT0WU
NCI-H526MmPoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYLP[HJ5UUN3ME2xMlkyOzlizszNNEXQem1USU6JRWK=
ME-180MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGHyOmFKSzVyPUGuPVM1PzdizszNNVj1XXk4W0GQR1XS
PFSK-1NGXhNnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEXHbFNKSzVyPUGuPVQ1PThizszNM1TkXHNCVkeHUh?=
TYK-nuM4Pmd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYPDUWZMUUN3ME2xMlk2QDJ|IN88US=>NUK1bnU{W0GQR1XS
HOSMlnBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWrtW3dZUUN3ME2xMlk4QTR6IN88US=>NXzXXYV5W0GQR1XS
T98GNGrvcG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmPpTWM2OD1zLkm5NFA3KM7:TR?=NEXSdGZUSU6JRWK=
SK-MES-1M1\YcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXHJR|UxRTJwMEGzN|Ih|ryPM{PPb3NCVkeHUh?=
SNB75NHHOfHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NW\Qd4p[UUN3ME2yMlAyPTRzIN88US=>MlnuV2FPT0WU
LAMA-84M4W1PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXu2T4F2UUN3ME2yMlAzPjh7IN88US=>NF\LUZhUSU6JRWK=
CAL-39NGXMZmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUXJR|UxRTJwMEOyPEDPxE1?NGCxcGRUSU6JRWK=
LOXIMVINIDqUHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTJwMESwPFQh|ryPNEWxdnlUSU6JRWK=
NH-12MkTUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX;Wd2FnUUN3ME2yMlA2PDJ2IN88US=>NGfTfnNUSU6JRWK=
NCI-H1048MoHjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4\TdWlEPTB;Mj6xNFUzKM7:TR?=NGfyWpJUSU6JRWK=
KS-1NFy2U5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2fGN2lEPTB;Mj6xNVAxOSEQvF2=MV7TRW5ITVJ?
NCI-N87Mme0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml;TTWM2OD1{LkGzN|g1KM7:TR?=NEPudYJUSU6JRWK=
CHP-212M1facmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkS1TWM2OD1{LkG4OFQzKM7:TR?=MknoV2FPT0WU
HCC1419MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV3rWWNIUUN3ME2yMlIyOTF3IN88US=>MUXTRW5ITVJ?
ES1M2HtNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHRTWM2OD1{LkKxN|I3KM7:TR?=NVj0VpJSW0GQR1XS
NCI-H2030M3LpZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGfYR5hKSzVyPUKuNlQyOjNizszNMYDTRW5ITVJ?
EW-22MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M17sV2lEPTB;Mj6yOVA3PyEQvF2=MXzTRW5ITVJ?
A431MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MU\JR|UxRTJwMkezOVQh|ryPNUjoc3BSW0GQR1XS
SF126MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4\6emlEPTB;Mj6zNFYzPSEQvF2=MoDwV2FPT0WU
SF295NUPzRoYyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3rFNmlEPTB;Mj6zNVUzPCEQvF2=NHzWN2RUSU6JRWK=
D-502MGMl3tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXzu[nExUUN3ME2yMlMzPDZzIN88US=>MYXTRW5ITVJ?
HCC2157M2Dpb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4LHc2lEPTB;Mj6zNlkzPyEQvF2=MUDTRW5ITVJ?
D-283MEDM3\ud2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIPXPWFKSzVyPUKuN|U6OjZizszNMkWxV2FPT0WU
SNU-423MoixS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXjJR|UxRTJwNECxO|Eh|ryPMXnTRW5ITVJ?
SK-LU-1NHHnU25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFy2d5lKSzVyPUKuOFQ2QDZizszNNU\YR|RLW0GQR1XS
22RV1M3nvNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF;PWVRKSzVyPUKuOFU3OTdizszNMVPTRW5ITVJ?
SW1088MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MW\JR|UxRTJwNEmyNVMh|ryPMYTTRW5ITVJ?
HT-3MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGGxN4JKSzVyPUKuOFkzPTlizszNMVTTRW5ITVJ?
NCI-H1666NEPjb29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlvaTWM2OD1{LkWxNVA1KM7:TR?=M3zJ[HNCVkeHUh?=
EM-2Mmj5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1T4cmlEPTB;Mj61NVE3QSEQvF2=NHzvPXFUSU6JRWK=
SNU-449NV7YUGpUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXnJR|UxRTJwNUewNVQh|ryPNHflSIlUSU6JRWK=
786-0MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVfJR|UxRTJwNUmyN|gh|ryPNF7ON2lUSU6JRWK=
SKG-IIIaMn\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHzLT5hKSzVyPUKuOlU6OzlizszNNWfuUIxbW0GQR1XS
MEL-HOMWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWO0NmkyUUN3ME2yMlY4PjN2IN88US=>M4\LVHNCVkeHUh?=
LCLC-97TM1MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGnpNlBKSzVyPUKuOlkzPjdizszNMUfTRW5ITVJ?
MKN7M4XTbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUXvcIFvUUN3ME2yMlcxPzV2IN88US=>NGXEXHNUSU6JRWK=
5637NXrJZoNDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4TkfWlEPTB;Mj63NVA{PSEQvF2=NUCwSppZW0GQR1XS
HOP-92M2PkPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3fyRWlEPTB;Mj63OFcyPyEQvF2=MUXTRW5ITVJ?
MDA-MB-157MkTGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmnZTWM2OD1{LkiyNFI{KM7:TR?=NWPpVohzW0GQR1XS
NB12NV7YWplYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFntOo1KSzVyPUKuPFQ6OTRizszNNVPrSFA2W0GQR1XS
DMS-273NV\QOFRrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mm\NTWM2OD1{Lki2OFch|ryPMYPTRW5ITVJ?
HCC70NIDWN2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mkn1TWM2OD1{Lki2OVg6KM7:TR?=MXLTRW5ITVJ?
YKG-1NGD4TWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXTJR|UxRTNwMEO3PFch|ryPMU\TRW5ITVJ?
NCI-H28NH;wRYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4LpfGlEPTB;Mz6wOVI6OSEQvF2=MkfXV2FPT0WU
HNMUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGK1RWZKSzVyPUOuNFY3OzZizszNM1\xZXNCVkeHUh?=
HT-1080M3HE[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHPnNHlKSzVyPUOuNFg3ODZizszNM1fKRnNCVkeHUh?=
HPAF-IIM3;sO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmqyTWM2OD1|LkGwNFY5KM7:TR?=MYDTRW5ITVJ?
U-2-OSNVS0Nnh5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX;Pc3ZNUUN3ME2zMlE{Pzh{IN88US=>NU\ENHpTW0GQR1XS
SNU-387MmG1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH36R49KSzVyPUOuNVY{PjRizszNM1L5TnNCVkeHUh?=
BeckerNEPrVoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2nvbWlEPTB;Mz6xOlgxQCEQvF2=NF:0NIpUSU6JRWK=
BHYM{Ky[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmTRTWM2OD1|LkK1OVcyKM7:TR?=MlWwV2FPT0WU
HTC-C3MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlXsTWM2OD1|LkK5N|UzKM7:TR?=MVvTRW5ITVJ?
M14MmC4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUfJR|UxRTNwM{C2OlMh|ryPNGqzSYFUSU6JRWK=
COR-L23NFPqT|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVvjSJFPUUN3ME2zMlM4Ojd7IN88US=>MmnnV2FPT0WU
C32M2r2[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTNwNEG1NFgh|ryPMV3TRW5ITVJ?
MewoNFz3OppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIG1e5ZKSzVyPUOuOFIyQDJizszNMYjTRW5ITVJ?
TE-8MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NELxVWRKSzVyPUOuOFgzPTlizszNM37zNHNCVkeHUh?=
RPMI-2650NXH4NHRLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NU\WcpJzUUN3ME2zMlYxPjN5IN88US=>NGjyOIZUSU6JRWK=
AGSMnjTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWHZW441UUN3ME2zMlYzPDZ2IN88US=>M1XPc3NCVkeHUh?=
MZ2-MELNYqyU5dWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXrTWM2OD1|Lk[2NVM5KM7:TR?=NU\2U2FZW0GQR1XS
Calu-3MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3fMeWlEPTB;Mz63NVI5PyEQvF2=NXn1RVRTW0GQR1XS
SJSA-1M1fpT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHnVVnRKSzVyPUOuO|E{OTVizszNM17ae3NCVkeHUh?=
SW962M{LBSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{TDdWlEPTB;Mz63NlY{PiEQvF2=Mm\UV2FPT0WU
PC-14M3HYcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1q2VGlEPTB;Mz63N|IzOiEQvF2=NX\JS|NpW0GQR1XS
SW1573MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFrqTW1KSzVyPUOuO|U{PDhizszNMVPTRW5ITVJ?
769-PMkjoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4XjU2lEPTB;Mz64Nlc1OyEQvF2=M{PvXnNCVkeHUh?=
KNS-62MnnyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml7QTWM2OD1|LkmyN|M5KM7:TR?=MXHTRW5ITVJ?
NCI-H747NETmSpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWSybo16UUN3ME20MlA2PjN6IN88US=>MUHTRW5ITVJ?
LN-405M3LPTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVu5UFlwUUN3ME20MlE2PzJ6IN88US=>M1jUO3NCVkeHUh?=
OVCAR-8MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUHJR|UxRTRwMkK1OFMh|ryPM3XCTXNCVkeHUh?=
DMS-114M3PBZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYPmZ5c6UUN3ME20MlI{QDlzIN88US=>M3;3S3NCVkeHUh?=
NCI-H2126M3TWcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkTlTWM2OD12LkK0OVU5KM7:TR?=MUDTRW5ITVJ?
TCCSUPNV\QfGM2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlnPTWM2OD12LkK0O|g5KM7:TR?=NUXJVIViW0GQR1XS
SK-N-FINVPjN41IT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYTJR|UxRTRwMkWzN|Ih|ryPNUXVeFRlW0GQR1XS
HCE-4MlfOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkX6TWM2OD12LkK3NVk4KM7:TR?=Mn3YV2FPT0WU
DK-MGNFPlWFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHvCSY5KSzVyPUSuN|A{QSEQvF2=M4DmZ3NCVkeHUh?=
RO82-W-1MlnNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH;obGFKSzVyPUSuN|I2QDRizszNMWXTRW5ITVJ?
A2780NEC0RmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHnqdnFKSzVyPUSuN|Y3QDJizszNM2foS3NCVkeHUh?=
ETK-1M3G2d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWni[VU{UUN3ME20MlM4ODV{IN88US=>M363UHNCVkeHUh?=
FADUMXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnnvTWM2OD12LkO3OFY4KM7:TR?=NHr2XmxUSU6JRWK=
CAL-12TNHHwTJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGLj[FBKSzVyPUSuOFE1OTNizszNNVHnU2VMW0GQR1XS
647-VNYnUNJplT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWfSdmdbUUN3ME20MlQ1ODJ{IN88US=>MV7TRW5ITVJ?
TGBC1TKBM3P3TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MU\JR|UxRTRwNEWxNVMh|ryPM{OyNHNCVkeHUh?=
LU-99ANWLK[pY1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MojBTWM2OD12LkS2NFYh|ryPMn\lV2FPT0WU
CAL-33NILpfIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkLBTWM2OD12LkWyOFU3KM7:TR?=MWjTRW5ITVJ?
LU-134-ANFPMTm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnTITWM2OD12LkWyO|Q2KM7:TR?=NV\qZZBIW0GQR1XS
NCI-H1355NV2wbHJuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{KzfGlEPTB;ND61OVE1PiEQvF2=MlPaV2FPT0WU
RPMI-7951NYThWJFsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV;NeHhWUUN3ME20MlU4ODB{IN88US=>NIrTUWpUSU6JRWK=
TE-1MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXL2XlV5UUN3ME20MlY3OTR|IN88US=>MknuV2FPT0WU
OE33NWrOSZRST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWXWWFg1UUN3ME20MlcxPTFzIN88US=>MVjTRW5ITVJ?
CAL-51NEThR5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{\RS2lEPTB;ND63NVA5OiEQvF2=NXjaR5pqW0GQR1XS
SW1783MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWfJR|UxRTRwN{WzNFgh|ryPM1jxZ3NCVkeHUh?=
BT-474NHniV4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX\JR|UxRTRwN{[zPFQh|ryPMWXTRW5ITVJ?
KYSE-520M1vad2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXnQdodvUUN3ME20Mlg4Ozl{IN88US=>MmjCV2FPT0WU
8-MG-BAM2TDNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVXJR|UxRTRwOEi1OVch|ryPMoG3V2FPT0WU
IA-LMMVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX[0XXR6UUN3ME20Mlk6PDN3IN88US=>MoXyV2FPT0WU
SW954NIXBZ3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVfJR|UxRTRwOUm0OFMh|ryPM134RnNCVkeHUh?=
RPMI-8226MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXz4WFNbUUN3ME21MlA2PDZzIN88US=>NFiyNnVUSU6JRWK=
MKN1M{KwU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIHQOnRKSzVyPUWuNFc6OjdizszNNGnZVlRUSU6JRWK=
A375NXHGdmdjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4LWXGlEPTB;NT6wPVI2PiEQvF2=NXHrOFJoW0GQR1XS
8305CNYSybIVqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXWzfpZPUUN3ME21MlA6QDh5IN88US=>MnHuV2FPT0WU
CAL-62M3XN[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUjJR|UxRTVwMUiyOVkh|ryPMkPzV2FPT0WU
NB10NEHQSZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnrtTWM2OD13LkKyO|Q1KM7:TR?=MkPPV2FPT0WU
OC-314NFPVTWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWnJR|UxRTVwM{e0OFQh|ryPMXHTRW5ITVJ?
PSN1NHuzRppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFzteHJKSzVyPUWuN|gzQDZizszNMl7wV2FPT0WU
GR-STMYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NETpS3BKSzVyPUWuN|g{OjJizszNMVnTRW5ITVJ?
P12-ICHIKAWAMY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{\ZSmlEPTB;NT60NFEh|ryPMWrTRW5ITVJ?
NCI-H1092NGfRc2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3XzdGlEPTB;NT60NVE1QCEQvF2=MV\TRW5ITVJ?
SCC-4M{fJcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGCyemNKSzVyPUWuOFE{PTVizszNNYW3UI16W0GQR1XS
TE-6M2KyU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4js[GlEPTB;NT60NVgyPiEQvF2=MW\TRW5ITVJ?
DOHH-2MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX;JR|UxRTVwNEKyOFgh|ryPMmPOV2FPT0WU
SW684NV;ONJE5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mnv4TWM2OD13Lk[2N|g2KM7:TR?=M3zPR3NCVkeHUh?=
CP50-MEL-BNVjFSY1NT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVfiUnF7UUN3ME21MlY5Pjh2IN88US=>NUK5TJlwW0GQR1XS
UM-UC-3NHLFPIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFriTHNKSzVyPUWuO|IzOzFizszNM2TreXNCVkeHUh?=
LC-2-adM3fPNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVzZV|RnUUN3ME21Mlc5OjVzIN88US=>M3zYfHNCVkeHUh?=
PC-3M4rpUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnfkTWM2OD13LkmxOlE2KM7:TR?=MmP4V2FPT0WU
CANMUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mm\yTWM2OD13LkmyPFIh|ryPM4TuSnNCVkeHUh?=
ESS-1NWrGUXRrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF:2RVJKSzVyPUWuPVc5PjlizszNM1;CcnNCVkeHUh?=
ATN-1M4XBPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3\6dWlEPTB;Nj6wOVU3QCEQvF2=NGHCPFJUSU6JRWK=
BxPC-3NX7r[3l1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYDKXWpDUUN3ME22MlA5OjF7IN88US=>MXzTRW5ITVJ?
KYSE-150MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{L2cWlEPTB;Nj6xNlQ4PiEQvF2=MUTTRW5ITVJ?
RPMI-8866NETROlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXXESWNnUUN3ME22MlE6OTZ|IN88US=>NF7mWpVUSU6JRWK=
SW780NFvweohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmDyTWM2OD14LkKwOFIh|ryPMom2V2FPT0WU
A388MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYDWT2U3UUN3ME22MlI{OTF3IN88US=>MkjaV2FPT0WU
NCI-H1437Mor6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVzJR|UxRTZwMkSwO|Mh|ryPMojFV2FPT0WU
NCI-H1755MoroS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4TC[mlEPTB;Nj6zOlYyOiEQvF2=Mny3V2FPT0WU
LS-123MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4DZPWlEPTB;Nj60NFUzOSEQvF2=NV;hdY9SW0GQR1XS
CaR-1M2HiXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVfJR|UxRTZwNE[zO|Mh|ryPNYPFNXZVW0GQR1XS
RT-112NEfmVZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYHheZhlUUN3ME22MlYxOzN6IN88US=>M2TlNnNCVkeHUh?=
CGTM2n2dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlHtTWM2OD14LkezOlgyKM7:TR?=NGLEOJNUSU6JRWK=
SW626MmDCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlTKTWM2OD14LkezPVQ3KM7:TR?=NILzVZNUSU6JRWK=
AsPC-1M3qzZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH\ldIFKSzVyPU[uO|Q2ODdizszNNGHmSGVUSU6JRWK=
SBC-5Mnj4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV\JR|UxRTZwOUeyPVch|ryPNHLXdXpUSU6JRWK=
SF539NGT5WXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWTJR|UxRTZwOUmzN|Mh|ryPNXfu[HhrW0GQR1XS
TI-73MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXPuUZpUUUN3ME23MlA3Ojh3IN88US=>NGjIU3hUSU6JRWK=
MHH-ES-1NUC4[3d[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4D5VWlEPTB;Nz6wO|c3OiEQvF2=MUjTRW5ITVJ?
KYSE-510NHvUXWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVrPPHQ4UUN3ME23MlA5PDN{IN88US=>M4LDV3NCVkeHUh?=
EW-1NFrFVXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUHJR|UxRTdwM{[5PVYh|ryPNInLZo5USU6JRWK=
SK-OV-3NX\RUnpQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlezTWM2OD15LkO5OFMzKM7:TR?=MkSwV2FPT0WU
MC-IXCNXHic2Q1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml7HTWM2OD15LkSxPVczKM7:TR?=NU\NTmpJW0GQR1XS
HSC-2MnvRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHT1PZBKSzVyPUeuOFI4ODVizszNMoLlV2FPT0WU
NCI-H2342MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHLwc2pKSzVyPUeuOVE1QSEQvF2=MYHTRW5ITVJ?
NCI-H1792MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXXJR|UxRTdwNUG3NVEh|ryPM1\PZ3NCVkeHUh?=
HT-1376MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{XKZWlEPTB;Nz64O|c4QCEQvF2=MUPTRW5ITVJ?
EW-13NUjHN2ZRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYLJR|UxRTdwOEm5O|ch|ryPM3jtVHNCVkeHUh?=
no-11MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUDJR|UxRTdwOUCxO|Qh|ryPM4rZSHNCVkeHUh?=
DaoyM2e0e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnvuTWM2OD15Lkm0N|IyKM7:TR?=MXjTRW5ITVJ?
COLO-800MmTqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFjaTWVKSzVyPUiuNFQyPjJizszNNVTS[odJW0GQR1XS
GB-1MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXLJR|UxRThwME[1OlUh|ryPM1rSZXNCVkeHUh?=
SJRH30MnTsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVvJR|UxRThwMUW4O|gh|ryPNV3RWY9CW0GQR1XS
NCI-H2291MknlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVTJR|UxRThwMkmxPFch|ryPM4W5eHNCVkeHUh?=
J82MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NITNOW5KSzVyPUiuNlk1QTFizszNMn[zV2FPT0WU
NCI-H596NFj6WHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVnaPVNKUUN3ME24MlMyPDV|IN88US=>Ml;MV2FPT0WU
RERF-LC-MSNWLPVm9uT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUfJR|UxRThwM{S4OVYh|ryPM3rld3NCVkeHUh?=
RH-18M3r6SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;4U2lEPTB;OD6zOVA1PiEQvF2=NXj1VJR[W0GQR1XS
SW48MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVjrXnZ3UUN3ME24MlU6PDV|IN88US=>NGfpXohUSU6JRWK=
RDMnrjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlnnTWM2OD16LkW5N|kyKM7:TR?=MlHsV2FPT0WU
MS-1NX65fGIxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH;abGhKSzVyPUiuOlE{QDdizszNMYDTRW5ITVJ?
ES6NUHxOHFGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlvuTWM2OD16LkezNVE6KM7:TR?=Mn\OV2FPT0WU
TE-12NGHScFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXvRdHdjUUN3ME24Mlc4PTB3IN88US=>Mmr0V2FPT0WU
DBTRG-05MGNHXWW2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MY\JR|UxRThwOUGyNVch|ryPNF;3fnZUSU6JRWK=
KINGS-1NXTDZpNYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml74TWM2OD16LkmyPVM5KM7:TR?=NUj1XJN{W0GQR1XS
HLENF\QeW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MY\JR|UxRThwOUO3PFUh|ryPMkO2V2FPT0WU
MHH-NB-11M3S4O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHJTWM2OD17LkCxPFM6KM7:TR?=NXfJPW5RW0GQR1XS
U-87-MGM37u[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3Hhe2lEPTB;OT6yOFMzOSEQvF2=M{jONXNCVkeHUh?=
MN-60MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3HBT2lEPTB;OT6yOFU1OiEQvF2=MUDTRW5ITVJ?
SASMlfpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHjO[ZNKSzVyPUmuNlU2QDFizszNMmH5V2FPT0WU
NCI-H446MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYnCWGxQUUN3ME25MlM3OSEQvF2=NI\RV2dUSU6JRWK=
C-33-AMnrYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYTJR|UxRTlwNEO5PFgh|ryPNUCzZlh6W0GQR1XS
RXF393MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFPvfYRKSzVyPUmuOFcxODJizszNM4HVdXNCVkeHUh?=
CGTH-W-1MoTyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXr0V5JbUUN3ME25MlQ6Ozh2IN88US=>M{\VVXNCVkeHUh?=
RCM-1NFTL[mtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVPOcYF5UUN3ME25MlY{QDBzIN88US=>NF;aZnpUSU6JRWK=
SN12CM4LHTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4Gzc2lEPTB;OT62OVM{QCEQvF2=NXnGdItrW0GQR1XS
KLENFe0NnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1jRc2lEPTB;OT63NFAxQSEQvF2=NHzSVG9USU6JRWK=
EFO-21M1rRS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmLkTWM2OD17Lke3N|gzKM7:TR?=M3m3dnNCVkeHUh?=
KYSE-70NVjCbIVbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4TnUmlEPTB;OT64PFAyOSEQvF2=MmLRV2FPT0WU
D-247MGNYfUe4d2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFj4SYtKSzVyPUGwMlA2PjhizszNMX;TRW5ITVJ?
MPP-89M2fBZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXjJR|UxRTFyLkC5OFYh|ryPNEfBd|dUSU6JRWK=
RVH-421NFr1Z3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{noXGlEPTB;MUCuNVUxPSEQvF2=MojHV2FPT0WU
NCI-H460MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NELDXG1KSzVyPUGwMlI5ODZizszNNVS2Z4RCW0GQR1XS
NOMO-1M4Licmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MW\JR|UxRTFyLkO1N|Ih|ryPM4Tv[XNCVkeHUh?=
DELNYDIeItjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEDFcXJKSzVyPUGwMlM4QTRizszNM4OxVHNCVkeHUh?=
HT55NUjDU4ZTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFO5O2JKSzVyPUGwMlYzODVizszNM2XBZnNCVkeHUh?=
MC116NUPvTYFDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVXJR|UxRTFyLk[2OVUh|ryPM4S0XXNCVkeHUh?=
BB30-HNCM1zj[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkTiTWM2OD1zMD62Olkh|ryPNY\yeVR4W0GQR1XS
DJM-1NYLSeVVpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWDJR|UxRTFyLk[5OFkh|ryPMVLTRW5ITVJ?
ZR-75-30Ml65S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3f3dmlEPTB;MUCuPVQ1OSEQvF2=M2TPO3NCVkeHUh?=
U-118-MGNF7RXGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFXscHdKSzVyPUGwMlk5QTZizszNNUnkOId3W0GQR1XS
MSTO-211HM{jReWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml3PTWM2OD1zMT6wO|E3KM7:TR?=MYDTRW5ITVJ?
SW837MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoK3TWM2OD1zMT6wPVQ6KM7:TR?=NFGybHpUSU6JRWK=
HuCCT1NHrHWZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NY\4cHk3UUN3ME2xNU4yOjhzIN88US=>M{jGfnNCVkeHUh?=
RCC10RGBMkDyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmWyTWM2OD1zMT6xN|Uh|ryPMn6zV2FPT0WU
NMC-G1NHrwOo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYLqfWRpUUN3ME2xNU4yPDl|IN88US=>Mn;VV2FPT0WU
NCI-H650NHewfpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlvZTWM2OD1zMT6zO|k1KM7:TR?=NF34UpRUSU6JRWK=
HEC-1M2Tme2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4LKUmlEPTB;MUGuOFMzQCEQvF2=NFHONm5USU6JRWK=
DU-4475NW\BeXFpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEnPSG5KSzVyPUGxMlc{QTNizszNM4LVUHNCVkeHUh?=
DSH1Ml:zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1LqVGlEPTB;MUGuO|YxPiEQvF2=NG\iSWZUSU6JRWK=
HCC1569NVTKWYsxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYfJR|UxRTFzLke2O|gh|ryPNXXVfnBsW0GQR1XS
HCC1187NI\VTodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVHJR|UxRTFzLki1PFgh|ryPNV\xR|RwW0GQR1XS
EW-11NWTXUWlMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmTHTWM2OD1zMT65OFc1KM7:TR?=MonZV2FPT0WU
LB2518-MELM3H5VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWrvfZNzUUN3ME2xNk4xPTlizszNNYCxSGpuW0GQR1XS
KALS-1M4SwVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnSzTWM2OD1zMj64OVU{KM7:TR?=M4m5RXNCVkeHUh?=
8505CM1jwR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MULJR|UxRTF{Lki4OUDPxE1?NG\pXFBUSU6JRWK=
SK-N-DZM2HFVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MorITWM2OD1zMz6wOFU{KM7:TR?=M2LndnNCVkeHUh?=
CHP-134M3[0Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWTJR|UxRTF|LkGxOVgh|ryPNHn4d3VUSU6JRWK=
HCE-TMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEG3XphKSzVyPUGzMlI{PjRizszNNXvse3ZLW0GQR1XS
LB-831-BLCNEG5WFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVzDNHd7UUN3ME2xN{43OjR4IN88US=>NY\2V2Y5W0GQR1XS
OVCAR-4MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlrRTWM2OD1zMz62OVI1KM7:TR?=MUHTRW5ITVJ?
SW756NWTEOmd2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2r2c2lEPTB;MUOuO|I1PiEQvF2=NULtTVRtW0GQR1XS
OCUB-MMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYrJR|UxRTF|LkixOVYh|ryPNUPlPFRrW0GQR1XS
SW982NXviXXNyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3TGemlEPTB;MUOuPFI4PiEQvF2=NYW2dItbW0GQR1XS
DBNX63XZZ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoWwTWM2OD1zMz64N|g1KM7:TR?=M3q2Z3NCVkeHUh?=
H-EMC-SSM4TwOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml\5TWM2OD1zMz65NVM6KM7:TR?=NVLRUYdHW0GQR1XS
VMRC-RCZM2T1Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF22fWhKSzVyPUG0MlAxOTVizszNMX\TRW5ITVJ?
CAKI-1M3jDU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3f1bWlEPTB;MUSuNFE{OiEQvF2=NFfDeIZUSU6JRWK=
GI-1NX[0VYZ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3LDSGlEPTB;MUSuNFY2QCEQvF2=NEnBRoxUSU6JRWK=
Ca9-22Mnf1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEfrWYNKSzVyPUG0MlYxPTRizszNMWfTRW5ITVJ?
TE-5M4DxTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo\wTWM2OD1zND63NlA5KM7:TR?=M1faUXNCVkeHUh?=
EFO-27NFr6SGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4DQcWlEPTB;MUSuO|YzOiEQvF2=NXnubpl6W0GQR1XS
CAL-72MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2nG[WlEPTB;MUSuO|c5OyEQvF2=NFr4TJRUSU6JRWK=
GP5dM1e4XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlPUTWM2OD1zNT6wOFc1KM7:TR?=MlK5V2FPT0WU
CAS-1MmThS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkjUTWM2OD1zNT6wOlYh|ryPMkCyV2FPT0WU
A2058MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYr6eVBkUUN3ME2xOU42PjN6IN88US=>MVnTRW5ITVJ?
PANC-08-13NWTyVGlCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkDWTWM2OD1zNT62PFU6KM7:TR?=MV7TRW5ITVJ?
Detroit562M4jKV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{nGcmlEPTB;MUWuPVE{QSEQvF2=NETkSWNUSU6JRWK=
PANC-10-05MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYDJR|UxRTF4LkC4NlEh|ryPNVW5cmxWW0GQR1XS
KOSC-2MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2LiV2lEPTB;MU[uNVEzPSEQvF2=M3LlXHNCVkeHUh?=
GT3TKBNUDrTmlsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUjzSW1rUUN3ME2xOk4yQThzIN88US=>M3H1ZnNCVkeHUh?=
KM-H2NU\MOXZGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml\ETWM2OD1zNj6zOlQ3KM7:TR?=NWfEPYM5W0GQR1XS
LB771-HNCNIHyW29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MY\JR|UxRTF4LkS0NlIh|ryPNV25NZJDW0GQR1XS
SF268NYfmS3pUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4iwfmlEPTB;MU[uOFUzKM7:TR?=NHzFSVdUSU6JRWK=
OE19NUnHcVRlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4PERWlEPTB;MU[uOVI1KM7:TR?=M4CxeHNCVkeHUh?=
MLMANHX5dXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFvRPXJKSzVyPUG2MlU2PzFizszNNInqR2VUSU6JRWK=
MDA-MB-231NUjnPIFNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2C0NWlEPTB;MU[uO|E{PiEQvF2=Ml7RV2FPT0WU
TGWMkm3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MULJR|UxRTF4LkixNFIh|ryPNVXRTW9TW0GQR1XS
MDA-MB-453NE\wfmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYL1Vm93UUN3ME2xO{4xODB|IN88US=>MoTuV2FPT0WU
SNU-C2BNIPreotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULXSWVHUUN3ME2xO{4xOjN5IN88US=>M{XIcnNCVkeHUh?=
A427MnPaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFnH[GpKSzVyPUG3MlI{OzRizszNMWjTRW5ITVJ?
SK-MEL-2MoK4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXvw[4lwUUN3ME2xO{4{OjF|IN88US=>NIfy[3RUSU6JRWK=
KURAMOCHIMUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3HzOmlEPTB;MUeuN|g6PyEQvF2=Mny5V2FPT0WU
IST-MEL1MlTUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVfve2x4UUN3ME2xO{46OTh{IN88US=>NITBOYZUSU6JRWK=
NCI-H1793NG\JbmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnPSTWM2OD1zOD6xOVgyKM7:TR?=NXflN2JsW0GQR1XS
HCC1395M3XndWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFrLV25KSzVyPUG4MlU3OTFizszNMoDpV2FPT0WU
NUGC-3MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NInRZmlKSzVyPUG4MlY2QDRizszNNVHHV3dNW0GQR1XS
BB65-RCCNHPyW5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3zsXGlEPTB;MUiuOlY6KM7:TR?=NHnkUXlUSU6JRWK=
RMG-INHLkW5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkXoTWM2OD1zOD63N|gzKM7:TR?=MX3TRW5ITVJ?
LS-513NH;FWmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXvJR|UxRTF6LkmyNlgh|ryPNFrIR5JUSU6JRWK=
MFM-223MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX;JR|UxRTF7LkC3NVYh|ryPNHfJUY5USU6JRWK=
NCI-H727Mli0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{nMZ2lEPTB;MUmuN|I6PSEQvF2=NILicVNUSU6JRWK=
KP-4M4TJV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NW\ncZpEUUN3ME2xPU45PTNzIN88US=>NEnWbIhUSU6JRWK=
NB13NYq5doN2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUDC[HE1UUN3ME2xPU45QDN7IN88US=>NFracFhUSU6JRWK=
UACC-893MlvUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHPaUmRKSzVyPUG5Mlk4PTdizszNM4iwSnNCVkeHUh?=
HT-1197MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1jtbmlEPTB;MkCuNlk2QCEQvF2=NGi5Zo1USU6JRWK=
NCI-H2029Mnf3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{GzOGlEPTB;MkCuN|I3PiEQvF2=NGHlNpBUSU6JRWK=
GI-ME-NNGTwfY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIfwbFhKSzVyPUKwMlM{PzNizszNMVHTRW5ITVJ?
OVCAR-3NYnsUWs2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWq5[YVQUUN3ME2yNE42QDJ{IN88US=>MX\TRW5ITVJ?
HD-MY-ZNETFUopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX\JR|UxRTJzLkO2PVYh|ryPMVnTRW5ITVJ?
NTERA-S-cl-D1NWLENmdST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1XOWWlEPTB;MkGuOlczOiEQvF2=MnzhV2FPT0WU
SCHNGG5THZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIXLellKSzVyPUKyMlQ6PiEQvF2=NIPmdpZUSU6JRWK=
KARPAS-299MojaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1jnUGlEPTB;MkOuN|g5PyEQvF2=M4HmenNCVkeHUh?=
NCI-H1650NInlT5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULZN2J5UUN3ME2yN{46OjRzIN88US=>MnPKV2FPT0WU
ACHNM3G1Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXPJR|UxRTJ2LkS2OVYh|ryPNWHvVVhsW0GQR1XS
M059JMVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYfJR|UxRTJ2LkW2N|Qh|ryPMn;aV2FPT0WU
AM-38NFHTbG1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYDJR|UxRTJ3LkS4NUDPxE1?NFjZZpBUSU6JRWK=
KG-1NWPmNIpkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlHvTWM2OD1{NT61OFk1KM7:TR?=MonRV2FPT0WU
COLO-824NFXtSZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV7JR|UxRTJ3LkW1PVkh|ryPM13BdHNCVkeHUh?=
NCI-H1155M2TsRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHTVUoNKSzVyPUK1MlU5PDdizszNMXTTRW5ITVJ?
NCI-H441MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3vxZ2lEPTB;MkWuO|Q3PSEQvF2=NVfoN45KW0GQR1XS
J-RT3-T3-5NGHDSY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXHJR|UxRTJ4LkOwNlch|ryPMWPTRW5ITVJ?
JEG-3NWPRc2x4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYLVUIMyUUN3ME2yOk43QDB3IN88US=>NFzR[XpUSU6JRWK=
RKOMn3rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYXJR|UxRTJ4Lke2N|Ih|ryPNYXpWXQ3W0GQR1XS
CAL-85-1M2P4N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2PJbGlEPTB;MkeuNlEyQCEQvF2=MkjGV2FPT0WU
CAL-120NHn2RVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEHRd4lKSzVyPUK3MlY6OTRizszNNVrETmo4W0GQR1XS
NCI-H2452MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYLhOGZIUUN3ME2yO{44PzF4IN88US=>MYjTRW5ITVJ?
NCI-H1395M4XLT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnPaTWM2OD1{Nz63PFM{KM7:TR?=NHTEVGRUSU6JRWK=
KYSE-450NFzGdGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUfJR|UxRTJ5Lkm4OlIh|ryPNIXqOZBUSU6JRWK=
S-117M1jEZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmX4TWM2OD1{OT6zPFU4KM7:TR?=NFGybnZUSU6JRWK=
SW13MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWLJR|UxRTJ7Lki1NVkh|ryPM1HEcHNCVkeHUh?=
ES3M4H1UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEL3SYtKSzVyPUOwMlM4OzNizszNM2\lS3NCVkeHUh?=
HCT-116MlixS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFnEWlRKSzVyPUOwMlU2PTRizszNMWjTRW5ITVJ?
NCI-H1693M{ntb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVHJR|UxRTNyLkW5OFIh|ryPMYLTRW5ITVJ?
VM-CUB-1NHP1VJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnTPTWM2OD1|MD62OFE{KM7:TR?=NYXjU4hUW0GQR1XS
NCI-H2170NEjGO5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEThWnVKSzVyPUOxMlU4QDRizszNNV\zTZVDW0GQR1XS
ALL-PONITPOWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkWyTWM2OD1|MT64OFI5KM7:TR?=MkjwV2FPT0WU
NCI-H661Mlv3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH3BR4RKSzVyPUOyMlA3OjNizszNM3ToSnNCVkeHUh?=
NCI-H2347NVmzeWU5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH\WXGJKSzVyPUOyMlQ5OzdizszNNV3lXXZNW0GQR1XS
FTC-133M1G1NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFHBVpNKSzVyPUOyMlcxPiEQvF2=MorLV2FPT0WU
COLO-829M2jx[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEfC[G5KSzVyPUOzMlM1PjdizszNNWHTUo4{W0GQR1XS
GOTOMmHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NW[xUnlCUUN3ME2zN{42OjV6IN88US=>MYHTRW5ITVJ?
YAPCM3fSN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFjpTo1KSzVyPUOzMlgyPTlizszNM16xb3NCVkeHUh?=
LCLC-103HNXPyOYJTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWLJR|UxRTN2LkG2NlQh|ryPNXywfnljW0GQR1XS
SiHaM1;JfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXXJR|UxRTN2LkO4NVch|ryPM1;IZnNCVkeHUh?=
LK-2Mn7vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{LFfGlEPTB;M{SuOVcxQCEQvF2=MYrTRW5ITVJ?
KP-N-YSNWH2SGJPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4nkUmlEPTB;M{SuO|IxOiEQvF2=NFHEb|dUSU6JRWK=
NCI-SNU-1MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmHMTWM2OD1|NT6xO|kh|ryPNGCzbVJUSU6JRWK=
KNS-81-FDMVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXLTVFNJUUN3ME2zOU43PjNizszNNV[2W2VRW0GQR1XS
SCC-9NHXMcHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MojQTWM2OD1|Nj63NVQ3KM7:TR?=MVfTRW5ITVJ?
SH-4M{\NSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{HHd2lEPTB;M{[uO|Mh|ryPNVrjPY16W0GQR1XS
HCC-1954MlXPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3LGR2lEPTB;M{euNlczQSEQvF2=MYHTRW5ITVJ?
BALL-1M2PHRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4LteGlEPTB;M{euOVMyPiEQvF2=NGrRUY9USU6JRWK=
BE-13NYTFWFRyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnfUTWM2OD1|Nz63NFE5KM7:TR?=MonXV2FPT0WU
COLO-678MkPIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoOyTWM2OD1|Nz65OFM4KM7:TR?=NVLsepNUW0GQR1XS
SK-MEL-3M{jhTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFXqSJhKSzVyPUO4MlI{QTdizszNMYfTRW5ITVJ?
OAW-28M33nWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFG3NFNKSzVyPUO4MlY{QSEQvF2=NIfxdY5USU6JRWK=
CAMA-1MnLCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGmwWpRKSzVyPUO4Mlk3QTFizszNMmDFV2FPT0WU
C2BBe1MkLSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkDCTWM2OD1|OT64NVgh|ryPNVXBcodyW0GQR1XS
A3-KAWNXf6UXltT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlzpTWM2OD12MD6zOlYyKM7:TR?=NV;P[m1VW0GQR1XS
SK-MEL-24MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTRyLkW5N|Eh|ryPMluyV2FPT0WU
KYSE-140M1vRc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUjJR|UxRTRyLkexOlUh|ryPMVTTRW5ITVJ?
MOLT-16MlHuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M37HZWlEPTB;NEGuNVU{PiEQvF2=NX\QWGNKW0GQR1XS
CFPAC-1MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXLJR|UxRTR{LkWyNVEh|ryPMXLTRW5ITVJ?
NB14MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX;JR|UxRTR{LkewNlch|ryPMmDCV2FPT0WU
COLO-792MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3rnWGlEPTB;NEKuPFk3OSEQvF2=NILubFVUSU6JRWK=
RH-1MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYDaVI1rUUN3ME20N{41QDN4IN88US=>MYnTRW5ITVJ?
NCI-H522NYrsfZBUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MofUTWM2OD12ND6zOVY5KM7:TR?=NEfVSpdUSU6JRWK=
Ca-SkiMoq5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M33ZUWlEPTB;NESuPFEyPCEQvF2=NWrZdpE4W0GQR1XS
KGNM3Hs[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFzmfHNKSzVyPUS4MlMxPjNizszNNIrHd3lUSU6JRWK=
UACC-62MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWfsbYxJUUN3ME20PE41ODd{IN88US=>MW\TRW5ITVJ?
NCI-H358M2DsSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWjJR|UxRTR7LkOwNVgh|ryPMUPTRW5ITVJ?
LS-411NMk\rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHuyO|lKSzVyPUS5MlMyOThizszNMljaV2FPT0WU
IST-MES1M1LoRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3HkNGlEPTB;NEmuOVYzPSEQvF2=MX3TRW5ITVJ?

... Click to View More Cell Line Experimental Data

In vivo Administration of GDC-0941 at 75 mg/kg/day displays significant inhibitory effect against established human U87MG glioblastoma xenografts in female NCr athymic mice, with tumor growth inhibition of 83%. [1] Oral administration of GDC-0941 at 150 mg/kg/day inhibits the growth of HER2-amplified, trastuzumab-resistant MDA-MB-361.1 xenografts in mice, and significantly delays the tumor progression, in association with potent induced apoptosis in tumors. [2] GDC-0941 (75 mg/kg/day) treatment for 2 weeks induces ~40% reduction in tumor volume of spontaneous B-cell follicular lymphomas developed in PTEN+/-LKB1+/hypo mice, accompanied by ablation of phosphorylation of Akt, S6K and SGK (serum and glucocorticoid protein kinase) protein kinases. [4]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

Scintillation proximity assay Recombinant human PI3Kα, PI3Kβ, and PI3Kδ are coexpressed in a Sf9 baculovirus system with the p85α regulatory subunit and purified as GST-fusion proteins using affinity chromatography on glutathione-sepharose. Recombinant human PI3Kγ is expressed as monomeric GST-fusions and purified similarly. GDC-0941 is dissolved in DMSO and added to 20 mM Tris-HCl (pH 7.5) containing 200 μg yttrium silicate (Ysi) polylysine SPA beads, 4 mM MgCl2, 1 mM dithiothreitol (DTT), 1 μM ATP, 0.125 μCi [γ-33P]-ATP, and 4% (v/v) DMSO in a total volume of 50 μL. The recombinant GST-fusion of PI3Kα (5 ng), PI3Kβ (5 ng), PI3Kδ (5 ng), or PI3Kγ (5 ng) is added to the assay mixture to initiate the kinase reaction. After incubation for 1 hour at room temperature, the kinase reaction is terminated with 150 μL PBS. The mixture is then centrifuged for 2 minutes at 2000 rpm and read using a Wallac Microbeta counter. The reported IC50 values are calculated using a sigmoidal, dose-response curve fit in MDL Assay Explorer.

Cell Assay: [2]

Cell lines SKBR-3, BT474-M1, AU-565, HCC-1419, ZR75-30, KPL-4, JIMT-1, BT474-EEI, HCC-1954, MCF-7, CALU-3, SKOV-3, and MKN-7 cells
Concentrations Dissolved in DMSO, final concentrations ~10 μM
Incubation Time 48 and 72 hours
Method Cells are exposed to various concentrations of GDC-0941 for 48, and 72 hours. Proliferation/viability of cells is detected by using the CellTiter-Glo Luminescent Cell Viability Assay. The pAkt (Ser473), cleaved caspase-3, and cleaved PARP are analyzed by western blot. The Caspase-Glo 3/7 assay and the Cell Death Detection ELISAplus assay are used to detect caspase 3/7 activity, and apoptosis, respectively.

Animal Study: [2]

Animal Models NCR nude mice implanted with MDA-MB-361.1 cells, and SCID, C.B-17/IcrHsd-Prkdcscid mice implanted subcutaneously with BT474-M1 cells
Formulation Dissolved in 10% DMSO, 5% Tween 20, 85% water
Dosages ~150 mg/kg/day
Administration Oral gavage

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Folkes AJ, et al. J Med Chem, 2008, 51(18), 5522-5532.

[2] Junttila TT, et al. Cancer Cell, 2009, 15(5), 429-440.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-30)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT02092831 Completed Healthy Volunteer Genentech, Inc. April 2014 Phase 1
NCT01740336 Active, not recruiting Breast Cancer Genentech, Inc. February 2013 Phase 2
NCT01493843 Completed Non-Squamous Non-Small Cell Lung Cancer Genentech, Inc. January 2012 Phase 2
NCT01437566 Completed Breast Cancer Genentech, Inc. October 2011 Phase 2
NCT01474668 Completed Healthy Volunteer Genentech, Inc. October 2011 Phase 1

view more

Chemical Information

Download Pictilisib (GDC-0941) SDF
Molecular Weight (MW) 513.64
Formula

C23H27N7O3S2

CAS No. 957054-30-7
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms RG7321
Solubility (25°C) * In vitro DMSO 44 mg/mL (85.66 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 2% DMSO+30% PEG 300+5% Tween 80+ddH2O 5mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidine

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related PI3K Products

  • GDC-0032

    GDC-0032 is a potent, next-generation β isoform-sparing PI3K inhibitor targeting PI3Kα/δ/γ with Ki of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3Kβ.

    Features:A beta isoform-sparing PI3K inhibitor.

  • Pilaralisib (XL147)

    Pilaralisib (XL147) is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ with IC50 of 39 nM/36 nM/23 nM in cell-free assays, less potent to PI3Kβ. Phase 1/2.

  • GNE-317

    GNE-317 is a potent, brain-penetrant PI3K inhibitor.

  • LY294002

    LY294002 is the first synthetic molecule known to inhibit PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM in cell-free assays, respectively; more stable in solution than Wortmannin, and also blocks autophagosome formation.

  • 3-Methyladenine (3-MA)

    3-Methyladenine (3-MA) is a selective PI3K inhibitor for Vps34 and PI3Kγ with IC50 of 25 μM and 60 μM in HeLa cells; blocks class I PI3K consistently, whereas suppression of class III PI3K is transient, and also blocks autophagosome formation.

  • CAL-101 (Idelalisib, GS-1101)

    CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM in cell-free assays; shown to have 40- to 300-fold greater selectivity for p110δ than p110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR.

  • Wortmannin

    Wortmannin is the first described PI3K inhibitor with IC50 of 3 nM in a cell-free assay, with little selectivity within the PI3K family. Also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM in cell-free assays.

  • BEZ235 (NVP-BEZ235, Dactolisib)

    BEZ235 (NVP-BEZ235, Dactolisib) is a dual ATP-competitive PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM in cell-free assays, respectively. Inhibits ATR with IC50 of 21 nM in 3T3TopBP1-ER cell.

  • BKM120 (NVP-BKM120, Buparlisib)

    BKM120 (NVP-BKM120, Buparlisib) is a selective PI3K inhibitor of p110α/β/δ/γ with IC50 of 52 nM/166 nM/116 nM/262 nM in cell-free assays, respectively. Reduced potency against VPS34, mTOR, DNAPK, with little activity to PI4Kβ. Phase 2.

  • Alpelisib (BYL719)

    Alpelisib (BYL719) is a potent and selective PI3Kα inhibitor with IC50 of 5 nM in a cell-free assay, and minimal effect on PI3Kβ/γ/δ. Phase 2.

Recently Viewed Items

Tags: buy Pictilisib (GDC-0941) | Pictilisib (GDC-0941) supplier | purchase Pictilisib (GDC-0941) | Pictilisib (GDC-0941) cost | Pictilisib (GDC-0941) manufacturer | order Pictilisib (GDC-0941) | Pictilisib (GDC-0941) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us